Scientific Sessions 2025  /  MolCel: Heart Failure: A State of Metabolic Imbalance  /  Metabolic Effects of the SGLT2 Inhibitor Dapagliflozin in Heart Failure Across the Spectrum of Ejection Fraction
Logo

American Heart Association

  44
  0

Final ID:

Metabolic Effects of the SGLT2 Inhibitor Dapagliflozin in Heart Failure Across the Spectrum of Ejection Fraction

  • Shah, Svati  ( DUKE UNIV MEDICAL CENTER , Hillsborough , North Carolina , United States )
    • Author Disclosures:
    Svati Shah: DO NOT have relevant financial relationships
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

MolCel: Heart Failure: A State of Metabolic Imbalance

Friday, 11/07/2025 , 08:00AM - 09:15AM

Cardiovascular Seminar

More abstracts on this topic:
Metabolite regulation of abnormal cardiac metabolism

Heather Lisa

Branch chain amino acids and cardiovascular disease

Newgard Christopher

More abstracts from these authors:
The Year in Genomic Medicine

Shah Svati, Schunkert Heribert

Metabolomic Profiling of SLGT2 Inhibitors in Heart Failure

Shah Svati

You have to be authorized to contact abstract author. Please, Login
Not Available